Homology Medicines: Q1 Earnings Snapshot
In this article:
BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Homology Medicines Inc. (FIXX) on Thursday reported a loss of $28.8 million in its first quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 50 cents.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.
The gene editing company posted revenue of $802,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX
